Načítá se...
Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with Sorafenib
BACKGROUND: Sorafenib can be considered as the effective option of treatment in patients with metastatic radioiodine refractory differentiated thyroid cancers. The cutaneous manifestations of Sorafenib include rash, desquamation, hand foot skin reactions, pruritus, alopecia and erythema. We report t...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3750499/ https://ncbi.nlm.nih.gov/pubmed/23937803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-13-29 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|